Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
”Myeloma Paper of the Day:
Multicenter retrospective study of prognostic factors of 10-year survival in pts post-ASCT finds kappa light chain type and post-ASCT therapy predict better OS; PS 2-4, HRCA, melphalan <200/m2, ISS III predicted shorter OS.”
Title: Prognostic factors of 10-year survival in patients with myeloma after autologous stem cell transplantation: a multicenter retrospective analysis
Authors: Kazuhito Suzuki, Ichiro Hanamura, Hiroyuki Takamatsu, Koji Kawamura, Emiko Sakaida, Masaki Ri, Keisuke Kataoka, Akira Hangaishi, Kazutaka Sunami, Akio Saito, Yuta Katayama, Noriko Doki, Hideyuki Nakazawa, Shinsuke Iida, Shingo Kurahashi, Shuichi Ota, Hitoji Uchiyama, Masashi Sawa, Yoshinobu Kanda, Junya Kanda, Yoshiko Atsuta, Shingo Yano, Nobuhiro Tsukada
You can read the full article on Leukemia and Lymphoma.

You can find other articles featuring Robert Orlowski on OncoDaily